TY - JOUR
T1 - Silicon Micro-and Nanofabrication for Medicine
AU - Fine, Daniel
AU - Grattoni, Alessandro
AU - Goodall, Randy
AU - Bansal, Shyam S.
AU - Chiappini, Ciro
AU - Hosali, Sharath
AU - van de Ven, Anne L.
AU - Srinivasan, Srimeenkashi
AU - Liu, Xuewu
AU - Godin, Biana
AU - Brousseau, Louis
AU - Yazdi, Iman K.
AU - Fernandez-Moure, Joseph
AU - Tasciotti, Ennio
AU - Wu, Hung Jen
AU - Hu, Ye
AU - Klemm, Steve
AU - Ferrari, Mauro
PY - 2013/5
Y1 - 2013/5
N2 - This manuscript constitutes a review of several innovative biomedical technologies fabricated using the precision and accuracy of silicon micro- and nanofabrication. The technologies to be reviewed are subcutaneous nanochannel drug delivery implants for the continuous tunable zero-order release of therapeutics, multi-stage logic embedded vectors for the targeted systemic distribution of both therapeutic and imaging contrast agents, silicon and porous silicon nanowires for investigating cellular interactions and processes as well as for molecular and drug delivery applications, porous silicon (pSi) as inclusions into biocomposites for tissue engineering, especially as it applies to bone repair and regrowth, and porous silica chips for proteomic profiling. In the case of the biocomposites, the specifically designed pSi inclusions not only add to the structural robustness, but can also promote tissue and bone regrowth, fight infection, and reduce pain by releasing stimulating factors and other therapeutic agents stored within their porous network. The common material thread throughout all of these constructs, silicon and its associated dielectrics (silicon dioxide, silicon nitride, etc.), can be precisely and accurately machined using the same scalable micro- and nanofabrication protocols that are ubiquitous within the semiconductor industry. These techniques lend themselves to the high throughput production of exquisitely defined and monodispersed nanoscale features that should eliminate architectural randomness as a source of experimental variation thereby potentially leading to more rapid clinical translation. The precision of silicon micro- and nanofabrication is used to create a range of innovative biomedical technologies. This review covers several of these technologies, including nanochannel implants, embedded vectors, nanowires, biocomposite porous silicon(pSi), and porous silica chips. The materials, silicon and its dielectrics, are produced using the high-throughput techniques ubiquitous within the semiconductor industry, with defined nanoscale features that could lead to rapid clinical translation.
AB - This manuscript constitutes a review of several innovative biomedical technologies fabricated using the precision and accuracy of silicon micro- and nanofabrication. The technologies to be reviewed are subcutaneous nanochannel drug delivery implants for the continuous tunable zero-order release of therapeutics, multi-stage logic embedded vectors for the targeted systemic distribution of both therapeutic and imaging contrast agents, silicon and porous silicon nanowires for investigating cellular interactions and processes as well as for molecular and drug delivery applications, porous silicon (pSi) as inclusions into biocomposites for tissue engineering, especially as it applies to bone repair and regrowth, and porous silica chips for proteomic profiling. In the case of the biocomposites, the specifically designed pSi inclusions not only add to the structural robustness, but can also promote tissue and bone regrowth, fight infection, and reduce pain by releasing stimulating factors and other therapeutic agents stored within their porous network. The common material thread throughout all of these constructs, silicon and its associated dielectrics (silicon dioxide, silicon nitride, etc.), can be precisely and accurately machined using the same scalable micro- and nanofabrication protocols that are ubiquitous within the semiconductor industry. These techniques lend themselves to the high throughput production of exquisitely defined and monodispersed nanoscale features that should eliminate architectural randomness as a source of experimental variation thereby potentially leading to more rapid clinical translation. The precision of silicon micro- and nanofabrication is used to create a range of innovative biomedical technologies. This review covers several of these technologies, including nanochannel implants, embedded vectors, nanowires, biocomposite porous silicon(pSi), and porous silica chips. The materials, silicon and its dielectrics, are produced using the high-throughput techniques ubiquitous within the semiconductor industry, with defined nanoscale features that could lead to rapid clinical translation.
UR - http://www.scopus.com/inward/record.url?scp=84879608077&partnerID=8YFLogxK
U2 - 10.1002/adhm.201200214
DO - 10.1002/adhm.201200214
M3 - Article
C2 - 23584841
AN - SCOPUS:84879608077
SN - 2192-2640
VL - 2
SP - 632
EP - 666
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 5
ER -